Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
J Hosp Infect ; 100(3): 270-275, 2018 Nov.
Article in English | MEDLINE | ID: mdl-29730141

ABSTRACT

INTRODUCTION: Antimicrobial stewardship programmes (ASPs) serve as the primary method to prevent and manage the development of antimicrobial resistance. Rural settings may lack the recommended personnel and resources needed to provide antimicrobial stewardship services. METHODS: An electronic survey was distributed via e-mail to pharmacy directors or antimicrobial stewardship programme directors of licensed hospitals within Public Health Region 4/5N of East Texas. RESULTS: Sixty percent of ASPs were established <12 months prior to the survey administration. All ASPs had pharmacist involvement, with only one (5%) having formal infectious diseases (ID) training through postgraduate education. Ninety percent of ASPs had a physician champion, with five (27.8%) physicians having formal ID training. Most institutions lacked one or more recommended antimicrobial stewardship practices. When compared with ASPs established for <12 months, ASPs existing for at least 12 months were more likely to have protocols to change antimicrobials from intravenous to enteral forms (100% vs 50%, P = 0.042), provide education to patients and families on appropriate antimicrobial use (87.5% vs 33.3%, P = 0.028), and track antimicrobial purchasing costs (87.5% vs 33.3%, P = 0.028). CONCLUSIONS: Institutions in rural settings require additional resources, personnel, and time to implement ASPs and perform various antimicrobial stewardship practices.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antimicrobial Stewardship , Health Services Research , Cross-Sectional Studies , Hospitals, Rural , Humans , Rural Population , Texas
2.
Cell Commun Adhes ; 10(1): 37-50, 2003.
Article in English | MEDLINE | ID: mdl-12881039

ABSTRACT

We examined BMP regulation of the gap junction gene Gjal (Cx43alpha1) using a series of lacZ reporter constructs containing up to 6.7 kbs of mouse Cx43alpha1 promoter sequence. Using transient transfection assays, we showed that BMP2, BMP4, and GDF5, but not BMP6 or BMP7, can modulate Cx43alpha1 promoter activity in the osteosarcoma cell line ROS17/2.8. Positive regulatory elements were found at the proximal and distal ends of the 6.7 kb promoter fragment, while negative regulatory elements were found in the intervening region. Comparison of Cx43alpha1 promoter sequences from the human vs. mouse showed five regions with significant sequence conservation, two of which contained Smad binding elements in conjunction with a BMP response element. Analysis of a transgenic mouse line containing a Cx43alpha1 promoter driven lacZ reporter construct revealed lacZ expression in the developing joints, an expression pattern similar to that previously reported for Gdf5. LacZ expression was also observed in axial regions of the skeletal anlage, which in situ hybridization analysis confirmed as sites of Gdf5 transcript expression. When the Cx43alpha1 promoter driven lacZ transgene was bred into the brachypodism mouse Gdf5(bpJ)(bp) harboring a Gdf5 loss of function mutation, lacZ expression was extinguished. This was observed in homozygous and heterozygous bp animals, suggesting that Cx43alpha1 promoter regulation by GDF5 is subject to haploinsufficiency. Overall, these observations are consistent with recent studies by others indicating a role for Cx43alpha1 in osteogenesis and osteoblastic function during mouse development.


Subject(s)
Bone Morphogenetic Proteins/metabolism , Connexin 43/biosynthesis , Connexin 43/genetics , Gene Expression Regulation, Developmental , Osteoblasts/metabolism , Promoter Regions, Genetic , Transforming Growth Factor beta , Amino Acid Motifs , Animals , Base Sequence , Bone Morphogenetic Protein 2 , Bone Morphogenetic Protein 4 , Bone Morphogenetic Protein 6 , Bone Morphogenetic Protein 7 , Conserved Sequence , Genes, Reporter , Growth Differentiation Factor 5 , Heterozygote , Homozygote , Humans , In Situ Hybridization , Lac Operon , Luciferases/metabolism , Mice , Mice, Transgenic , Models, Genetic , Molecular Sequence Data , Mutation , Plasmids/metabolism , Protein Binding , RNA, Messenger/metabolism , Sequence Homology, Nucleic Acid , Transcription, Genetic , Transfection , beta-Galactosidase/metabolism
3.
Osteoarthritis Cartilage ; 11(6): 442-54, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12801484

ABSTRACT

OBJECTIVE: Cartilage oligomeric matrix protein (COMP) mutations have been identified as responsible for two arthritic disorders, multiple epiphyseal dysplasia (MED) and pseudoachondroplasia (PSACH). However, the function of COMP in chondrogenic differentiation is largely unknown. Our investigation focuses on analyzing the function of normal COMP protein in cartilage biology. METHODS AND RESULTS: To explore the function of COMP we make use of an in vitro model system for chondrogenesis, consisting of murine C3H10T1/2 mesenchymal cells maintained as a high-density micromass culture and stimulated with bone morphogenetic protein 2 (BMP-2). Under these culture conditions, C3H10T1/2 cells undergo active chondrogenesis in a manner analogous to that of embryonic limb mesenchymal cells, and have been shown to serve as a valid model system to investigate the mechanisms regulating mesenchymal chondrogenesis. Our results indicate that ectopic COMP expression enhances several early aspects of chondrogenesis induced by BMP-2 in this system, indicating that COMP functions in part to positively regulate chondrogenesis. Additionally, COMP has inhibitory effects on proliferation of cells in monolayer. However, at later times in micromass culture, ectopic COMP expression in the presence of BMP-2 causes an increase in apoptosis, with an accompanying reduction in cell numbers in the micromass culture. However, the remaining cells retain their chondrogenic phenotype. CONCLUSIONS: These data suggest that COMP and BMP-2 signaling converge to regulate the fate of these cells in vitro by affecting both early and late stages of chondrogenesis.


Subject(s)
Cell Differentiation/physiology , Chondrogenesis/physiology , Extracellular Matrix Proteins/physiology , Glycoproteins/physiology , Mesoderm/physiology , Transforming Growth Factor beta , Animals , Blotting, Northern , Bone Morphogenetic Protein 2 , Bone Morphogenetic Proteins/physiology , Cells, Cultured , Electrophoresis, Polyacrylamide Gel/methods , In Situ Hybridization , Matrilin Proteins , Mice , RNA/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction/methods
5.
J Exp Zool ; 291(3): 274-81, 2001 Oct 15.
Article in English | MEDLINE | ID: mdl-11598915

ABSTRACT

The turtle shell, an evolutionarily novel structure, contains a bony exoskeleton that includes a dorsal carapace and a ventral plastron. The development of the carapace is dependent on the carapacial ridge (CR), a bulge in the dorsal flank that contains an ectodermal structure analogous to the apical ectodermal ridge (AER) of the developing limb (Burke. 1989a. J Morphol 199:363-378; Burke. 1989b. Fortschr Zool 35:206-209). Although the CR is thought to mediate the initiation and outgrowth of the carapace, the mechanisms of shell development have not been studied on the molecular level. Here, we present data suggesting that carapace formation is initiated by co-opting genes that had other functions in the ancestral embryo, specifically those of limb outgrowth. However, there is divergence in the signaling repertoire from that involved in limb initiation and outgrowth. In situ hybridizations with antisense riboprobes derived from Trionyx spiniferous fibroblast growth factor-10 (tfgf10) and Trachemys scripta (T. scripta) fibroblast-growth factor 8 (tfgf8) cDNAs were performed on sections of early T. scripta embryos (< 30 days). Expression of tfgf10 was localized to the mesenchyme subjacent to the ectoderm of the CR. In the chick limb bud, FGF10 is known to be expressed in the early limb-forming mesenchyme and is capable of inducing FGF8 in the AER to initiate the outgrowth of the limb bud. Although the expression of tfgf8 was found in the AER of the developing turtle limb, it was not seen in the CR. Thus, the initiation of the carapace is in agreement with FGF10 expression in the CR, but FGF8 does not appear to have a role in mediating early carapace outgrowth.


Subject(s)
Biological Evolution , Bone Development/genetics , Fibroblast Growth Factors/biosynthesis , Gene Expression Regulation, Developmental , Turtles/genetics , Animals , Base Sequence , Embryonic Development , Fibroblast Growth Factors/pharmacology , In Situ Hybridization , Molecular Sequence Data , Turtles/anatomy & histology , Turtles/growth & development
6.
Evol Dev ; 3(2): 47-58, 2001.
Article in English | MEDLINE | ID: mdl-11341674

ABSTRACT

The turtle shell is an evolutionary novelty that is synapomorphic for chelonians. The carapace is initiated by the entrapment of the ribs by the carapacial ridge (CR), a lateral bulge of the dorsal ectoderm and dermal mesoderm. The mechanisms by which the CR is initiated, the ribs entrapped and the dorsal dermis ossified, remains unknown. Similarly, the formation of the plastron remains unexplained. Here, we present a series of anatomical investigations into plastron and carapace formation in the red-eared slider, Trachemys scripta, and the snapping turtle, Chelydra serpentina. We document the entrapment of the ribs by the CR and the formation of the plastron and carapacial bones by intramembranous ossification. We note the formation of the ossification centers around each rib, which suggest that the rib is organizing dermal ossification by secreting paracrine factors. The nuchal ossification center is complex and appears to involve multiple bone-forming regions. Individual ossification centers at the periphery of the carapace form the peripheral and pygial bones. The intramembranous ossification of the plastron proceeds from nine distinct ossification centers, and there appear to be interactions between the spicules of apposing centers as they draw near each other.


Subject(s)
Morphogenesis , Turtles/anatomy & histology , Animal Structures , Animals , Species Specificity , Turtles/embryology
7.
Arthritis Rheum ; 41(2): 246-55, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9485082

ABSTRACT

OBJECTIVE: To pharmacologically and functionally characterize calcium-mobilizing purine receptors on adherent human rheumatoid synovial cells. METHODS: Fura-2-loaded synovial cells were screened for changes in cytosolic calcium concentration after the addition of purine receptor agonists. Release of interleukin-1 (IL-1) and prostaglandin E2 (PGE2) was assessed by enzyme-linked immunosorbent assay (ELISA) and radioimmunoassay, respectively. The effect of IL-1 prestimulation on purine-mediated PGE2 release was determined. RESULTS: ATP (1-100 microM) and UTP (1-100 microM), but not 2-methylthio-ATP or adenosine, stimulated mobilization of calcium from intracellular stores in synovial cells. ATP and UTP stimulated a small, but significant, increase in PG release from resting synoviocytes and a dramatic increase in PG release from synoviocytes prestimulated with recombinant human IL-1alpha. Neither ATP nor UTP stimulated synoviocyte release of IL-1 as measured by specific ELISA. The effects of ATP and UTP on PG secretion were mimicked by phorbol 12-myristate 13-acetate and thapsigargin, and blocked by BAPTA buffering of cytosolic calcium. CONCLUSION: Adherent human rheumatoid synovial cells mobilize intracellular calcium via a P2U-like purine receptor. P2U receptor agonists stimulate PGE2 release from synoviocytes, an effect that is greatly enhanced by IL-1alpha prestimulation and blocked by intracellular calcium buffering.


Subject(s)
Arthritis, Rheumatoid/metabolism , Calcium/metabolism , Dinoprostone/metabolism , Receptors, Purinergic/metabolism , Synovial Membrane/metabolism , Adenosine Triphosphate/pharmacology , Adolescent , Adult , Aged , Arthritis, Rheumatoid/pathology , Buffers , Drug Synergism , Humans , Interleukin-1/pharmacology , Middle Aged , Purinergic Agonists , Receptors, Purinergic/drug effects , Synovial Membrane/drug effects , Synovial Membrane/pathology , Tetradecanoylphorbol Acetate/pharmacology , Thapsigargin/pharmacology , Uridine Triphosphate/pharmacology
8.
Am J Vet Res ; 57(4): 554-9, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8712524

ABSTRACT

OBJECTIVE: To investigate whether recombinant human bone morphogenetic protein-2 (rhBMP-2) regulates glycosaminoglycan (GAG) synthesis and release from equine articular cartilage explant cultures. DESIGN: Equine articular cartilage explants were maintained in vitro for 7 days in the presence of 0 (control), 1, 10, or 100 ng of rhBMP-2/ml. Synthesis and release of GAG were assessed as measures of production and degradation of the extracellular matrix, respectively. ANIMALS: 6 horses (age range, 2 to 25 years old) without clinically detectable musculoskeletal abnormalities. PROCEDURE: Rate of synthesis of GAG was assessed by incorporation of [36S]sulfate during the final 24 hours of the 7-day incubation period. Release of GAG was assessed on days 3, 6, and 7, using 1,9-dimethylmethylene blue. RESULTS: Explants from all 6 horses had a significant (P = 0.05) increase in release of GAG in response to incubation with 100 ng of rhBMP-2/ml. There was a significant (P = 0.05) decrease in GAG synthesis in explants from only 2 of the 6 horses at the same concentration of rhBMP-2. There was no significant age correlation between responsive and nonresponsive horses. CONCLUSIONS: A concentration of 100 ng of rhBMP-2/ml stimulates GAG release from explant cultures of equine articular cartilage. The data suggest that bone morphogenetic proteins may be potential regulators of equine cartilage degradation and repair. CLINICAL RELEVANCE: Surgical procedures that damage subchondral bone may stimulate generation of improved cartilage-like tissue. It is, therefore, crucial to understand how bone-derived factors may influence cartilage metabolism in horses.


Subject(s)
Cartilage, Articular/metabolism , Glycosaminoglycans/metabolism , Growth Substances/pharmacology , Proteins/pharmacology , Animals , Bone Morphogenetic Proteins , Cartilage, Articular/cytology , Cartilage, Articular/drug effects , Cell Division/drug effects , Cell Survival/drug effects , Glycosaminoglycans/biosynthesis , Horses , Humans , Kinetics , Metacarpophalangeal Joint , Organ Culture Techniques , Recombinant Proteins/pharmacology , Sulfates/metabolism , Sulfur Radioisotopes , Time Factors
9.
Tissue Eng ; 2(2): 115-25, 1996.
Article in English | MEDLINE | ID: mdl-19877934

ABSTRACT

Alginate-embedded chondrocytes have been used for experimental analysis of cartilage matrix metabolism and as a potential bioartificial system for repairing cartilage defects. Alginates are linear copolymers composed of 1,4-linked beta-n-mannuronic acid and 1,4 linked alpha-L-guluronic acid, which occur as regions made up exclusively of one unit or the other, or as regions in which the monomers approximate an alternating sequence. Data presented here demonstrate that the mannuronic to guluronic acid (M/G) ratio and molecular weight of the alginate utilized effects the tissue-culture handling properties of the resultant gel and the activity of embedded chondrocytes. In experiments comparing chondrocyte survival and matrix synthesis, optimal conditions were obtained with an alginate of both high mannuronic acid content and high molecular weight. Chondrocytes survived and proliferated when maintained in unsupplemented media, in media supplemented with fetal calf serum, and in media supplemented with the defined serum replacement ITS+ (6.25 microg/ml insulin, 6.25 microg/ml transferrin, 6.25 ng/ml selenous acid, 1.25 mg/ml bovine serum albumin, 5.35 microg/ml linoleic acid). High cell survival rate and increase in cell number was obtained in the absence of serum. In contrast, long-term matrix synthesis and deposition required media supplementation as indicated by uptake of [(35)S]sulfate into glycosaminoglycans and by immunofluorescence using antibodies specific for cartilage matrix molecules.

SELECTION OF CITATIONS
SEARCH DETAIL
...